Chlorhexidine 0.02% or polyhexamethylene biguanide 0.02% as the main treatment for Acanthamoeba keratitis
Аннотация
Acta Ophthalmologica, Volume 104, Issue 8, Page 868-872, December 2026.
Acta Ophthalmologica, Volume 104, Issue 8, Page 868-872, December 2026.
Abstract Purpose To compare the efficacy of intravitreal dexamethasone (DEX) implant‐based regimen versus ranibizumab‐based regimen for managing retinal exudation and complications in stage 3 Coats' disease. Methods Thirty‐seven eyes...
Abstract Foundation models are rapidly emerging as a major development in ophthalmic artificial intelligence, largely because they can achieve strong downstream performance with fewer labelled images than conventional supervised models,...
Abstract Purpose To evaluate intraretinal fluid (IRF) volume dynamics after switching from aflibercept 2 mg to faricimab in eyes with diabetic macular oedema (DME), stratified by prior response to aflibercept. Methods This retrospective...
Abstract Purpose Neovascular age‐related macular degeneration (AMD) is a common chronic disease with substantial societal impact. The validity of approaches to identify neovascular AMD in the Danish National Patient Registry (DNPR)...
Abstract Purpose To compare corneal endothelial cell (CEC) loss, central corneal thickness (CCT) and intraoperative complications 1 month post‐phacoemulsification using bevel‐up versus bevel‐down tip orientation with the direct‐chop...